Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-10
1998-07-07
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 23, 514866, A61K 3800, A61K 3170
Patent
active
057768870
ABSTRACT:
Nutritional composition for use by diabetics containing a controlled absorbed carbohydrate component. The carbohydrate component contains a rapidly absorbed fraction such as glucose or sucrose, a moderately absorbed fraction such as certain cooked starches or fructose, and a slowly absorbed fraction such as raw corn starch.
REFERENCES:
patent: 4921877 (1990-05-01), Cashmere et al.
patent: 5292723 (1994-03-01), Audrey et al.
patent: 5470839 (1995-11-01), Laughlin et al.
Diabetes Care, 17, pp. 519-522, 1994.
Brand et al., Diabetes Care, 14, pp. 95-101, 1991.
P. H. Parker et al., "Nutritional Management of Glycogen Storage Disease", Ann. Res. Nutr., 13, pp. 83-109, 1993.
Y.-T. Chen et al., "Type-I Glycogen Storage Disease: Nine Years of Management with Cornstarch", Eur. J. Pediatr., 152(suppl. 1), pp. S56-S59, 1993.
J. I. Wolfsdorf et al., "Continuous Glucose For Treatment of Patients with Type 1 Glycogen-Storage Disease: Comparison of the Effects of Dextrose and Uncooked Cornstarch on Biochemical Variables.sup.1-4 ", J. Clin. Nurt., 52, pp. 1043-1050, 1990.
G. P. A. Smit et al., "The Dietary Treatment of Children with Type I Glycogen Storage Disease with Slow Release Carbohydrate", Pediatric Research, vol. 18, No. 9, pp. 879-881, 1984.
K. M. Behall et al., "Effect of Long-Term, Consumption of Amylose vs Amylopectin Starch on Metabolic Variables in Human Subjects.sup.1-4 ", Am. J. Clin. Nutr., 61, pp. 334-340, 1995.
A. Raben et al., "Resistant Starch: The Effect on Postprandial Glycemia, Hormonal Response, and Satiety.sup.1-3 ", Am. J. Clin. Nutr., 60, pp. 544-551, 1990.
Monograph for Glytrol.
Greene Harry L.
Keating Kim R.
Lee Yung-Hsiung
Wibert Gregory J.
Bristol--Myers Squibb Company
Weddington Kevin E.
LandOfFree
Diabetic nutritional product having controlled absorption of car does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diabetic nutritional product having controlled absorption of car, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diabetic nutritional product having controlled absorption of car will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1205838